Vident Advisory’s Medtronic MDT Stock Holding History

Vident Advisory's MDT Position: Q2 2026 in Review

Vident Advisory reduced its Medtronic (MDT) stake by 16% in Q2 2026, selling an estimated $1.29M and leaving 82,127 shares worth $6.42M. The position accounts for 0.05% of the portfolio, ranked #329.

Vident Advisory first reported a position in MDT in Q3 2023 and has held it in 12 quarters since. The position peaked at $8.5M in Q1 2026. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

• Vident Advisory held 82,127 shares of Medtronic worth $6.42M as of Q2 2026.
• Vident Advisory sold 15,945 Medtronic shares in Q2 2026, an estimated $1.29M.
• Medtronic made up 0.05% of Vident Advisory's portfolio in Q2 2026, its #329 holding.
• Vident Advisory first reported a position in Medtronic in Q3 2023 and has held it in 12 quarters since.
• Vident Advisory's Medtronic position peaked at $8.5M in Q1 2026.
• 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.